@misc{indiciae692c924adc64,
  title = {TP53 abnormalities correlate with immune infiltration and are associated with response to flotetuzumab, an investigational immunotherapy, in acute myeloid leukemia},
  author = {Lai, C. and Vadakekolathu, J. and Reeder, S. and Church, S. E. and Hood, T. and Aldoss, I. and Godwin, J. and Wieduwilt, M. J. and Arellano, M. and Muth, J. and Ravandi, F. and Sweet, K. and Altmann, H. and Foulds, G. A. and Stolzel, F. and Middeke, J. M. and Ciciarello, M. and Curti, A. and Valk, P. J. M. and Lowenberg, B. and Bornhauser, M. and DiPersio, J. F. and Davidson-Moncada, J. K. and Rutella, S.},
  year = {2020},
  doi = {10.1101/2020.02.28.961391},
  url = {https://www.biorxiv.org/content/10.1101/2020.02.28.961391v1},
  note = {Source identifier: 10.1101/2020.02.28.961391}
}